Core Insights - Nutanix, Inc. (NASDAQ:NTNX) is recognized as an oversold global stock with potential for investment [1] - The company reported a 13% year-over-year revenue growth in Q1, totaling $670.6 million, which was slightly below expectations due to deferred deal start dates [2] - Analyst Sanjit Singh from Morgan Stanley maintained a "Buy" rating while adjusting the price target to $82, citing strong operational performance and growth metrics [2] Financial Performance - Nutanix's fiscal Q1 2026 results showed resilient demand for its hybrid multicloud platform, with bookings slightly exceeding expectations [3] - Free cash flow for the quarter was reported at $174.5 million, an increase from $151.9 million in Q1 2025 [3] - Non-GAAP net income per share (diluted) was $0.41, reflecting a year-over-year increase of $0.05 [4] Operational Strength - The company achieved an 18% growth in Annual Recurring Revenue (ARR) and a 17% expansion in net-new ARR [2] - Management maintained FY26 operating margin guidance and raised the free cash flow outlook for the year, indicating confidence in future performance [4] - Continued momentum is supported by expanded collaborations with partners such as Dell and Microsoft [4] Customer Base - Nutanix serves over 29,000 customers globally, focusing on delivering a unified hybrid multicloud software platform [5]

Core Viewpoint - Nutanix's stock fell over 18% after reporting earnings that were below analyst expectations and providing a weak forward outlook, indicating a pre-existing structural decline that was anticipated [1]. Group 1: Stock Performance and Analysis - Nutanix completed its Cakra formation and broke out in Phase 9, leading to a significant ascent, with a peak around $83.36 before entering a descent phase [2][4]. - The stock has since declined approximately 43% from its peak, which is considered normal for a descent leg in its current cycle [2]. - The current selling pressure aligns with the structural expectation that the stock will revisit the Cakra breakout level of around $31 [6]. Group 2: Future Projections - Nutanix is currently in Phase 12, with expectations that Phases 12 and 13 will focus on completing the descent, followed by a consolidation phase [7]. - Clarity regarding future performance will emerge when Phase 14 begins, which will determine the potential for a strong rally in Phase 18, referred to as Nirvana [7]. Group 3: Investor Sentiment - In July, most institutional ratings on Nutanix were bullish, but a cautious analysis highlighted structural risks and advised restraint [10]. - The descent is not complete until the stock approaches the ~$31 region, suggesting that new long positions are premature at this stage [11].

Core Insights - U.S. stock markets are experiencing early trading gains despite a technical outage at CME Group, with major indexes set for significant weekly advances but monthly declines in November [1][4][5] Premarket Activity and Futures Movements - U.S. stock futures indicated slight gains before a technical issue at CME Group halted trading, with Nasdaq 100 futures up 0.2% to 0.3%, S&P 500 futures rising 0.1% to 0.2%, and Dow futures gaining 0.1% to 0.2% [2] - ETFs tracking major indices also showed premarket gains, with SPY, QQQ, and DIA up 0.7%, 0.8%, and 0.7% respectively [2] Commodity Markets - WTI crude futures rose 0.7% to $59.10 per barrel, while gold futures increased by 0.5% to around $4,220 to $4,221 per ounce [3] - Bitcoin continued its upward trend, trading between $91,300 and $91,450, with Coinbase Global seeing a premarket jump of 2.6% to 2.7% [3] Major Market Indexes - Major U.S. equities indexes are on track for their most significant weekly gains since June, with Nasdaq Composite up 4.2%, S&P 500 up approximately 3.2%, and Dow Jones Industrial Average up about 2.6% [4] - Despite these weekly gains, all three major indexes are expected to end November in negative territory, with Nasdaq down 2.15% to 2.2%, S&P 500 down 0.4%, and Dow down 0.29% to 0.3% [5] Market Sentiment - Market sentiment is driven by optimism regarding AI stocks and expectations of a Federal Reserve interest rate cut in December, with futures pricing reflecting over 80% probability of a quarter-point cut [5] Upcoming Market Events - Key economic releases to watch include the Manufacturing Conditions ISM for November on December 1 and the Services Conditions ISM on December 3 [6] - Core Private Final Consumption Deflator inflation data and Personal Spending data for September are expected on December 5 [6] Major Stock News and Corporate Developments - CME Group shares ticked lower in premarket trading following the technical outage [12] - Robinhood Markets shares gained 1.5% in premarket trading, building on an almost 11% surge earlier in the week [12] - Alphabet shares rose 1% to 1.5% after unveiling its advanced Gemini 3 AI model, nearing a $4 trillion market capitalization [12] - Jefferies Financial Group stock edged lower after reports of an SEC investigation [12] - Deere & Co. shares tumbled 5.7% after missing earnings estimates and providing a cautious outlook [12] - HP Inc. shares fell 1.4% following fourth-quarter revenues that lagged behind estimates [12] - Nutanix Inc. shares plunged 17.8% after revenues came in below expectations [12] - Workday Inc. plummeted 7.9% after failing to meet revenue guidance [12] - Symbotic shares jumped 12.95% after analysts raised price targets [12] - Zscaler declined 13.03% following price target cuts and cautious guidance [12] - Micron Technology gained 3.24% amid continued activity in AI and semiconductor sectors [12] - Nordic American Tankers reported a net book loss but announced a consistent dividend [12] - Wipro announced a multi-year partnership to revamp its IT landscape [12] - Tata Consultancy Services signed a five-year agreement with SAP for modernization [12] - Adani Enterprises subsidiary assumed operational control of AGHPort Aviation Services [12] - Refex Industries secured a significant order worth ₹100 crore [12]

Market Overview - U.S. equity markets are experiencing a shortened trading session on Black Friday, with futures contracts for major indexes showing modest gains, indicating a cautiously optimistic start [1][2] - The Dow Jones Industrial Average (DJIA) closed at 47,427.12, up 0.7%, while the S&P 500 (SPX) and Nasdaq Composite (IXIC) also saw gains of 0.7% and 0.8% respectively, driven by optimism in AI stocks and expectations for a Federal Reserve interest rate cut [3][4] Economic Data - Initial jobless claims decreased by 6,000 to 216,000 for the week ended November 22, while continuing claims rose by 7,000 to 1.96 million for the week ended November 15 [5] - Durable goods orders for September increased by 0.5%, falling short of the Zacks Consensus Estimate of 2.2% [5] Federal Reserve Outlook - Traders are pricing in an 87% probability of a 25-basis-point interest rate cut by the Federal Reserve in December, with further reductions expected next year, influencing market sentiment positively [6] Corporate Developments - Deere & Co. (DE) shares fell 5.7% after reporting fourth-quarter fiscal 2025 adjusted earnings of $3.93 per share, missing estimates [7] - HP Inc. (HPQ) experienced a 1.4% decline in stock price due to fourth-quarter fiscal 2025 revenues of $14,639 million falling short of expectations [7] - Nutanix Inc. (NTNX) shares dropped 17.8% after first-quarter fiscal 2026 revenues of $670.58 million missed estimates [7] - Workday Inc. (WDAY) plummeted 7.9% after failing to meet market expectations for full fiscal subscription revenue guidance [11] - AppLovin Corp. (APP) gained 5.5% in the Nasdaq on Wednesday [11] - Sandisk (SNDK) is set to join the S&P 500, with its stock soaring 512% since its split from Western Digital earlier in 2025 [11] - Nordic American Tankers Ltd. (NAT) announced a $0.13 per share dividend and plans for two new Suezmax tankers [11]

Core Insights - Nutanix Inc. (NASDAQ:NTNX) experienced a significant decline of 17.75% in stock price, closing at $48.34, due to a cautious outlook following a revenue shift in Q1 FY2026 [1][3]. Financial Performance - For the first quarter of the fiscal year ending October 31, 2025, Nutanix reported a revenue increase of 13% to $670.6 million, up from $591 million year-on-year [2]. - Annual recurring revenues rose by 18% to $2.28 billion, compared to $1.94 billion in the previous year [2]. Future Guidance - The company anticipates Q2 revenues to be between $705 million and $715 million, with a non-GAAP operating margin targeted at 20.5% to 21.5% [4]. - For the full fiscal year, Nutanix aims for total revenues between $2.82 billion and $2.86 billion [4]. Management Commentary - The CFO of Nutanix indicated that while bookings were slightly higher than expected, there was a revenue shift from Q1 to future periods, which has been factored into the updated revenue guidance for Q2 and the full year [3].

Core Insights - Nutanix's stock fell nearly 18% following a disappointing quarterly earnings report, reflecting market sensitivity to guidance misses [1] Financial Performance - For fiscal Q1 2026, Nutanix reported a revenue increase of 13% year-over-year, totaling $670.6 million, and a net income rise of 18% to $120.9 million ($0.41 per share) [2] - Annual recurring revenue (ARR) grew by 18%, reaching just under $2.3 billion [2][3] Analyst Expectations - The reported revenue was below the average analyst expectation of $676.9 million, although non-GAAP profitability met consensus estimates [3] - Guidance for the current second quarter is projected at $705 million to $715 million, significantly lower than the analyst consensus of nearly $749 million [5] - For the fiscal year, management anticipates revenue between $2.82 billion and $2.86 billion, while analysts project $2.92 billion [6] Market Reaction - The market's reaction to the guidance misses has been severe, indicating a lack of tolerance for such discrepancies in the current environment [7] - Despite the disappointing guidance, Nutanix continues to show growth potential and demand for its services, suggesting that the market's reaction may be an overreaction [7]

Group 1 - The article emphasizes the importance of protecting investment portfolios from potential downturns in 2026, as stock market multiples are currently at multi-year highs [1] - Gary Alexander, with extensive experience in technology companies and startups, provides insights into industry trends and themes shaping the market [1] Group 2 - The article does not provide any specific company or stock recommendations, focusing instead on general market conditions and investment strategies [2][3]

Market Overview - U.S. markets opened with modest gains, with Nasdaq Futures leading at +0.52%, followed by S&P 500 Futures at +0.33% and Dow at +0.22% [5][6] Economic Indicators - Chicago PMI for November reported at 36.3, significantly below the consensus of 44.3, marking the second lowest reading since the pandemic and the 24th consecutive month of decline [2] - U.S. jobless claims decreased to 216,000 for the week of Nov. 22, down from 222,000 the previous week and below expectations of 225,000, indicating potential stabilization in the job market [3] - Durable goods orders for September increased by 0.5%, surpassing the expected 0.3%, driven by a 30.9% rise in defense aircraft/parts, although this growth rate was slower than the 3% gain in August [4] Company Performance Winners - Petco Health saw a significant increase of 21.9% following strong earnings reported after the previous market close [5] - Other notable gainers included Autodesk (+7.7%), Bentley Systems (+6.7%), and Oracle (+6%) [5] Losers - Nutanix experienced a sharp decline of 11.3% after disappointing earnings results [7] - Zscaler fell by 7% due to conservative guidance, while Reynolds and Workday dropped by 6.3% and 6.2% respectively, with Workday providing a weak boost to its full-year guidance [7]

Core Insights - Nutanix, Inc. reported worse-than-expected first-quarter financial results and cut its FY26 sales guidance below estimates [1] - The company posted revenue of $670.58 million, slightly below estimates of $676.75 million, while adjusted EPS was 41 cents, in line with expectations [1] - Nutanix expects second-quarter revenue between $705 million and $740 million, lower than the estimate of $749.09 million, and has revised its full-year revenue outlook for FY26 to $2.82 billion to $2.86 billion, down from the previous estimate of $2.92 billion [2] Analyst Reactions - Needham analyst Mike Cikos maintained a Buy rating on Nutanix but lowered the price target from $80 to $65 [4] - B of A Securities analyst Wamsi Mohan also maintained a Buy rating while reducing the price target from $93 to $75 [4] - Keybanc analyst Brandon Nispel kept an Overweight rating and cut the price target from $95 to $65, while Piper Sandler analyst James Fish reiterated an Overweight rating and lowered the price target from $88 to $72 [4] Market Reaction - Following the earnings announcement, Nutanix shares dipped 15.5% to trade at $49.69 [2]

Core Insights - U.S. stock futures are up, with Nasdaq futures increasing by approximately 50 points [1] - Nutanix Inc reported disappointing first-quarter financial results, leading to a significant drop in its stock price [2] Company Performance - Nutanix reported earnings of 21 cents per share, missing the analyst consensus estimate of 41 cents per share [2] - Quarterly sales for Nutanix were $670.576 million, falling short of the analyst consensus estimate of $676.750 million [2] - Following the earnings report, Nutanix shares fell by 16.8% to $48.86 in pre-market trading [2] Other Stocks Movement - Jiayin Group Inc (ADR) saw a decline of 7.8% to $6.83 in pre-market trading [4] - Zscaler Inc dropped 7.2% to $269.00 after reporting first-quarter financial results [4] - Ambarella Inc's stock fell 6.7% to $84.84 following its quarterly results [4] - Workday, Inc. declined 6.3% to $219.00 after its third-quarter results [4] - Pagerduty Inc decreased by 5.8% to $14.30 after mixed third-quarter results and lowered FY26 sales guidance [4] - HP Inc fell 5.7% to $22.94 after issuing first-quarter EPS guidance below estimates [4] - Deere & Company declined 4.7% to $474.95 after reporting fourth-quarter results and a worse-than-expected FY26 outlook [4] - Vera Therapeutics, Inc. dropped 3.5% to $28.40 in pre-market trading [4]